FAQ’s About MonaLisa Touch
Just like you, many postmenopausal women are experiencing changes from decreased estrogen that can affect their quality of life in unexpected ways. This can result in Vulvovaginal Atrophy (also called Genitourinary Syndrome of Menopause) which has symptoms such as: Vaginal dryness Vaginal burning Vaginal itching Painful intercourse (dyspareunia) Painful urination (dysuria) Vulvar discomfort Lichens sclerosus Vulvadynia.
The in-office procedure is virtually painless, requires no anesthesia and typically is done under 5 minutes. Treatments are spaced every 6 weeks for best results for a total of 3 treatments. Some women may require more treatments based on individual needs/ Many women experience results as early as 2 weeks post-procedure but to achieve maximum benefit women should complete all three treatments.
Most women report slight localized discomfort following the laser treatment and during the first few days after the session. Many have reported to have resumed their normal routine after one to three days. During the healing period, it may be recommended to avoid lifting weights or some activities, such as taking a hot bath, or physical exercise. Sexual Activity can be resumed after 5-7 days.
MonaLisa Touch is a new therapy that treats the symptoms of Vulvovaginal Atrophy that you may be experiencing. MonaLisa Touch is a fractional CO2 laser with a vaginal probe that delivers controlled energy to the vaginal tissue (mucosa) to revitalize the cells so they make more collagen, elastin and vascularization and moisture is increased. There is also a Vulvar probe which delivers energy to the vulvar region.
Yes, MonaLisa Touch treatment is a great option and particularly well suited for patients who cannot, or prefer not to receive estrogen therapy.
MonaLisa Touch is currently not covered by managed care or commercial insurance as no processing code has been established.
The MonaLisa Touch therapy has more than 8 clinical studies published. In addition to clinical studies, the MonaLisa Touch is the only therapy that has published histological data. MonaLisa Touch is FDA approved for treatment of genitourinary changes of menopause.